Notch Signaling Induces Cytoplasmic CD3 Epsilon Expression in Human Differentiating NK Cells
Overview
Affiliations
It has been proposed that heterogeneity in natural killer (NK)-cell phenotype and function can be achieved through distinct thymic and bone marrow pathways of NK-cell development. Here, we show a link between Notch signaling and the generation of intracellular CD3epsilon (cyCD3)-expressing NK cells, a cell population that can be detected in vivo. Differentiation of human CD34(+) cord blood progenitors in IL-15-supplemented fetal thymus organ culture or OP9-Delta-like 1 (DL1) coculture resulted in a high percentage of cyCD3(+) NK cells that was blocked by the gamma-secretase inhibitor DAPT. The requirement for Notch signaling to generate cyCD3(+) NK cells was further illustrated by transduction of CD34(+) cord blood (CB) cells with either the active intracellular part of Notch or the dominant-negative mutant of mastermind-like protein 1 that resulted in the generation of NK cells with respectively high or low frequencies of cyCD3. Human thymic CD34(+) progenitor cells displayed the potential to generate cyCD3(+) NK cells, even in the absence of Notch/DL1 signaling. Peripheral blood NK cells were unable to induce cyCD3 expression after DL1 exposure, indicating that Notch-dependent cyCD3 expression can only be achieved during the early phase of NK-cell differentiation.
Fang M, Allen A, Luo C, Finn J Front Immunol. 2024; 15:1457629.
PMID: 39281684 PMC: 11392856. DOI: 10.3389/fimmu.2024.1457629.
Single-Nuclei Characterization of Lacrimal Gland in Scopolamine-Induced Dry Eye Disease.
Tang Y, Dou S, Wei C, Sun Z, Sun D, Zhou Q Invest Ophthalmol Vis Sci. 2024; 65(4):46.
PMID: 38687491 PMC: 11067549. DOI: 10.1167/iovs.65.4.46.
Thymic NK-Cells and Their Potential in Cancer Immunotherapy.
Forbes C, Nierkens S, Cornel A Immunotargets Ther. 2024; 13:183-194.
PMID: 38558927 PMC: 10979679. DOI: 10.2147/ITT.S441639.
Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
Makino K, Long M, Kajihara R, Matsueda S, Oba T, Kanehira K J Immunother Cancer. 2022; 10(1).
PMID: 35101945 PMC: 8804689. DOI: 10.1136/jitc-2021-003827.
T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma.
Sparger E, Chang H, Chin N, Rebhun R, Withers S, Kieu H Front Vet Sci. 2021; 8:772932.
PMID: 34926643 PMC: 8674490. DOI: 10.3389/fvets.2021.772932.